What do systematic reviews say?

Intervention not reported

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 498 participants
  GRADE not reported

Intervention not reported

The intervention showed no clear difference in FOM (1 RCT, 32 participants); GRADE not reported.

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 0.44 [0.11, 1.72]
  1 study · 32 participants
  GRADE not reported

Intervention not reported

The intervention showed no clear difference in BEV+HSPPC96 1 RCTs; 53 participants) (low certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 1.01 [0.33, 3.1]
  1 study · 96 participants
  Low

Intervention not reported

The intervention showed no clear difference in BEV+ONA(1 RCT; 64 participants) (low certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 1.17 [0.57, 2.39]
  1 study · 64 participants
  Low

Intervention not reported

The intervention showed no clear difference in BEV+CAB (1 RCT; 58 participants) (low certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 1.27 [0.61, 2.66]
  1 study · 58 participants
  Low

Intervention not reported

The intervention showed no clear difference in BEV+DAS (2 RCTs, 83 participants) (high certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 0.52 [0.69, 3.34]
  2 studies · 83 participants
  High

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  19 studies · 1847 participants
  GRADE not reported

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 799 participants
  GRADE not reported

Intervention not reported

It is very uncertain whether the intervention changes PUL (UroLift) (mixed estimate) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 2.39 [0.51, 11.1]
  Studies not reported
  Very low

Intervention not reported

It is very uncertain whether the intervention changes PAE (mixed estimate) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 4.39 [1.25, 15.44]
  Studies not reported
  Very low

Intervention not reported

The intervention may leads to higher TUMT (mixed estimate) (low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 9.71 [2.35, 40.13]
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

It is very uncertain whether the intervention changes CRFWVT (Rezūm) (pairwise) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 1.36
  Studies not reported
  Very low

Intervention not reported

It is very uncertain whether the intervention changes TIND (pairwise) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 0.67
  Studies not reported
  Very low